I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Belantamab Mafodotin in Patients with Relapsed/Refractory M..:
Javier de la Rubia
;
Rafael Alonso
;
María Esther Clavero
...
https://www.mdpi.com/2072-6694/15/11/2964. , 2023
Link:
https://doi.org/10.3390/cancers15112964
RT Journal T1
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:dd8a1864f6d54f82b3a5188ca4961fd8&Exemplar=1&LAN=DE A1 Javier de la Rubia A1 Rafael Alonso A1 María Esther Clavero A1 Elham Askari A1 Alfonso García A1 Cristina Antón A1 Margarita Fernández A1 Fernando Escalante A1 Ana García A1 Rafael Rios-Tamayo A1 Venancio Conesa A1 María Arancha Bermúdez A1 Beatriz Merchán A1 Alberto E. Velasco A1 María Jesús Blanchard A1 Antonia Sampol A1 Eukene Gainza A1 Prisma Montserrat Hernández A1 Adrián Alegre PB MDPI AG YR 2023 K1 belantamab mafodotin K1 multiple myeloma K1 relapse K1 refractory K1 treatment K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/15/11/2964 LK http://dx.doi.org/https://doi.org/10.3390/cancers15112964 DO https://doi.org/10.3390/cancers15112964 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)